Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. (Q36246359)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Y Ravindranath

1

1 reference

Europe PubMed Central

13 August 2017

M Chang

2

1 reference

Europe PubMed Central

13 August 2017

C P Steuber

3

1 reference

Europe PubMed Central

13 August 2017

D Becton

4

1 reference

Europe PubMed Central

13 August 2017

G Dahl

5

1 reference

Europe PubMed Central

13 August 2017

C Civin

6

1 reference

Europe PubMed Central

13 August 2017

B Camitta

7

1 reference

Europe PubMed Central

13 August 2017

A Carroll

8

1 reference

Europe PubMed Central

13 August 2017

S C Raimondi

9

1 reference

Europe PubMed Central

13 August 2017

H J Weinstein

10

1 reference

Europe PubMed Central

13 August 2017

Pediatric Oncology Group

11

1 reference

Europe PubMed Central

13 August 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

13 August 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

13 August 2017

19

1 reference

Europe PubMed Central

13 August 2017

12

1 reference

Europe PubMed Central

13 August 2017

2101-2116

1 reference

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403927

0 references

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Down syndrome, drug metabolism and chromosome 21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

Effect of altering conditions of the sequence method on baroreflex sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

21 January 2018

A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy for childhood acute myeloid leukemia: role of allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Who should be transplanted for AML?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403927

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403927

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36246359&oldid=2004433053"